Leggi l’articolo in italiano

World Obesity Day should not be another awareness ritual, but a moment to reassess the policies that have shaped our metabolic landscape. With over one billion people affected globally and prevalence rates having tripled since 1975, obesity is no longer just a health emergency; it is a systemic crisis hindering social progress and economic growth. It is time to acknowledge that obesity is not a failure of individual willpower, but a complex, chronic, and relapsing medical condition where human biology interacts with misaligned economic, food, and social systems. 

For decades, public policy has focused on the “eat less and move more” mantra, centering on health education and individual responsibility. However, evidence suggests this approach is incomplete and often ineffective, as excess adiposity is frequently intertwined with trauma, socioeconomic stress, neurodivergence, and biological adaptation. Framing weight solely as a “lifestyle choice” ignores the scientific basis of the disease and fuels a systemic stigma that alienates patients from care. This bias often leads to “diagnostic overshadowing,” where healthcare professionals dismiss or overlook serious symptoms — such as those of heart failure — by attributing them solely to a patient’s weight.

Rethinking Choice Architecture

We do not operate in a neutral food environment. The current composition of household purchases is the result of a production ecosystem shaped by decades of policies originally oriented toward caloric security. This is compounded by a high-speed daily life which, due to time constraints, makes the convenience of available options the most immediate response to consumer needs. The challenge for the next decade is not to multiply isolated or punitive tools like taxes or alarmist labels — interventions that have shown a limited impact on long-term obesity prevalence — but to rebalance the market by aligning economic incentives with metabolic health. The objective must be to design contexts that support citizen resilience, while strictly preserving the fundamental principle of consumer freedom of choice. 

The arrival of next-generation incretin therapies (GLP-1 receptor agonists) represents a technological tipping point, offering weight loss comparable to surgery. However, medication is not a standalone panacea; rapid weight loss can lead to lean tissue loss accounting for up to 40% of the total reduction, making structured, multidisciplinary nutritional support and routine monitoring essential. Innovation is powerful only when integrated into comprehensive chronic care models where primary healthcare plays a leading role. Pragmatic programs like PATHWEIGH have demonstrated that utilizing electronic health records to prioritize weight management in primary care can favorably shift population health trajectories with minimal additional effort. Ultimately, addressing obesity requires governance capable of aligning food, healthcare, and economic systems around long-term metabolic resilience and sustainable growth. 

Francesca Orsini, PhD – Nutritionist and Researcher. 

.